HEADER SUGAR BINDING PROTEIN 13-MAR-00 1ELJ TITLE THE CRYSTAL STRUCTURE OF LIGANDED MALTODEXTRIN-BINDING PROTEIN FROM TITLE 2 PYROCOCCUS FURIOSUS CAVEAT 1ELJ GLC B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTODEXTRIN-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS FURIOSUS; SOURCE 3 ORGANISM_TAXID: 2261; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PKM800 KEYWDS PROTEIN-CARBOHYDRATE COMPLEX, MALTOSE BINDING PROTEIN, MBP FOLD, ABC KEYWDS 2 TRANSPORTER FOLD, THERMOPHILIC PROTEIN, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.G.EVDOKIMOV,E.D.ANDERSON,K.M.ROUTZAHN,D.S.WAUGH REVDAT 6 30-OCT-24 1ELJ 1 HETSYN LINK REVDAT 5 29-JUL-20 1ELJ 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 24-JUL-19 1ELJ 1 REMARK LINK REVDAT 3 24-FEB-09 1ELJ 1 VERSN REVDAT 2 01-APR-03 1ELJ 1 JRNL REVDAT 1 19-JAN-01 1ELJ 0 JRNL AUTH A.G.EVDOKIMOV,D.E.ANDERSON,K.M.ROUTZAHN,D.S.WAUGH JRNL TITL STRUCTURAL BASIS FOR OLIGOSACCHARIDE RECOGNITION BY JRNL TITL 2 PYROCOCCUS FURIOSUS MALTODEXTRIN-BINDING PROTEIN. JRNL REF J.MOL.BIOL. V. 305 891 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11162100 JRNL DOI 10.1006/JMBI.2000.4202 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 4.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.196 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.184 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2253 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 42982 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3040 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 387 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.070 REMARK 3 ANGLE DISTANCES (A) : 1.200 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED CONJUGATED GRADIENT LEAST SQUARES REMARK 3 PROCE REMARK 4 REMARK 4 1ELJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1000010703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35220 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.0 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 2.4 M AMMONIUM SULFATE, 0.1 REMARK 280 M BICINE-HCL. DROP: 6 MG/ML PROTEIN 1:1 WITH RESERVOIR, PH 9.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.55900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.86300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.41600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.86300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.55900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.41600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 381 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 4 CE LYS A 282 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 210 CB - CG - CD2 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A 221 CD - NE - CZ ANGL. DEV. = 15.2 DEGREES REMARK 500 ARG A 221 NE - CZ - NH1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ARG A 221 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 45 76.15 -117.92 REMARK 500 ASP A 146 69.99 -160.76 REMARK 500 ASP A 253 54.68 36.49 REMARK 500 ASP A 358 62.91 -169.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 GLU A 4 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 MALTOTRIOSE IS A TRISACCHARIDE, COMPOSED OF THREE REMARK 600 GLUCOPYRANOSIDE UNITS LINKED BY ALPHA 1->4 BONDS. REMARK 600 IN OUR STRUCTURE WE OBSERVE THAT THE REDUCING END REMARK 600 OF THE MOLECULE IS DISORDERED BETWEEN TWO ANOMERIC REMARK 600 FORMS - ALPHA AND BETA. THIS IS WHY GLC 1001 HAS REMARK 600 TWO ANOMERIC OXYGENS, EACH HAVING PARTIAL OCCUPANCY. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OMP RELATED DB: PDB REMARK 900 E. COLI MBP REMARK 900 RELATED ID: 3MBP RELATED DB: PDB REMARK 900 E. COLI MBP + MALTOTRIOSE REMARK 900 RELATED ID: 4MBP RELATED DB: PDB REMARK 900 E. COLI MBP + MALTOTETRAOSE DBREF 1ELJ A 6 381 UNP P58300 MALE_PYRFU 59 434 SEQRES 1 A 381 MET LYS ILE GLU GLU GLY LYS VAL VAL ILE TRP HIS ALA SEQRES 2 A 381 MET GLN PRO ASN GLU LEU GLU VAL PHE GLN SER LEU ALA SEQRES 3 A 381 GLU GLU TYR MET ALA LEU CME PRO GLU VAL GLU ILE VAL SEQRES 4 A 381 PHE GLU GLN LYS PRO ASN LEU GLU ASP ALA LEU LYS ALA SEQRES 5 A 381 ALA ILE PRO THR GLY GLN GLY PRO ASP LEU PHE ILE TRP SEQRES 6 A 381 ALA HIS ASP TRP ILE GLY LYS PHE ALA GLU ALA GLY LEU SEQRES 7 A 381 LEU GLU PRO ILE ASP GLU TYR VAL THR GLU ASP LEU LEU SEQRES 8 A 381 ASN GLU PHE ALA PRO MET ALA GLN ASP ALA MET GLN TYR SEQRES 9 A 381 LYS GLY HIS TYR TYR ALA LEU PRO PHE ALA ALA GLU THR SEQRES 10 A 381 VAL ALA ILE ILE TYR ASN LYS GLU MET VAL SER GLU PRO SEQRES 11 A 381 PRO LYS THR PHE ASP GLU MET LYS ALA ILE MET GLU LYS SEQRES 12 A 381 TYR TYR ASP PRO ALA ASN GLU LYS TYR GLY ILE ALA TRP SEQRES 13 A 381 PRO ILE ASN ALA TYR PHE ILE SER ALA ILE ALA GLN ALA SEQRES 14 A 381 PHE GLY GLY TYR TYR PHE ASP ASP LYS THR GLU GLN PRO SEQRES 15 A 381 GLY LEU ASP LYS PRO GLU THR ILE GLU GLY PHE LYS PHE SEQRES 16 A 381 PHE PHE THR GLU ILE TRP PRO TYR MET ALA PRO THR GLY SEQRES 17 A 381 ASP TYR ASN THR GLN GLN SER ILE PHE LEU GLU GLY ARG SEQRES 18 A 381 ALA PRO MET MET VAL ASN GLY PRO TRP SER ILE ASN ASP SEQRES 19 A 381 VAL LYS LYS ALA GLY ILE ASN PHE GLY VAL VAL PRO LEU SEQRES 20 A 381 PRO PRO ILE ILE LYS ASP GLY LYS GLU TYR TRP PRO ARG SEQRES 21 A 381 PRO TYR GLY GLY VAL LYS LEU ILE TYR PHE ALA ALA GLY SEQRES 22 A 381 ILE LYS ASN LYS ASP ALA ALA TRP LYS PHE ALA LYS TRP SEQRES 23 A 381 LEU THR THR SER GLU GLU SER ILE LYS THR LEU ALA LEU SEQRES 24 A 381 GLU LEU GLY TYR ILE PRO VAL LEU THR LYS VAL LEU ASP SEQRES 25 A 381 ASP PRO GLU ILE LYS ASN ASP PRO VAL ILE TYR GLY PHE SEQRES 26 A 381 GLY GLN ALA VAL GLN HIS ALA TYR LEU MET PRO LYS SER SEQRES 27 A 381 PRO LYS MET SER ALA VAL TRP GLY GLY VAL ASP GLY ALA SEQRES 28 A 381 ILE ASN GLU ILE LEU GLN ASP PRO GLN ASN ALA ASP ILE SEQRES 29 A 381 GLU GLY ILE LEU LYS LYS TYR GLN GLN GLU ILE LEU ASN SEQRES 30 A 381 ASN MET GLN GLY MODRES 1ELJ CME A 33 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 33 10 HET GLC B 1 13 HET GLC B 2 11 HET GLC B 3 11 HET SO4 A1101 5 HET SO4 A1102 5 HET SO4 A1103 5 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 GLC 3(C6 H12 O6) FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 HOH *387(H2 O) HELIX 1 1 GLN A 15 LEU A 32 1 18 HELIX 2 2 ASN A 45 ILE A 54 1 10 HELIX 3 3 TRP A 69 ALA A 76 1 8 HELIX 4 4 THR A 87 ASN A 92 1 6 HELIX 5 5 ALA A 95 MET A 102 1 8 HELIX 6 6 THR A 133 TYR A 145 1 13 HELIX 7 7 PRO A 147 GLU A 150 5 4 HELIX 8 8 ASN A 159 GLN A 168 1 10 HELIX 9 9 LYS A 186 ILE A 200 1 15 HELIX 10 10 TRP A 201 MET A 204 5 4 HELIX 11 11 ASP A 209 GLU A 219 1 11 HELIX 12 12 GLY A 228 TRP A 230 5 3 HELIX 13 13 SER A 231 ALA A 238 1 8 HELIX 14 14 ASN A 276 SER A 290 1 15 HELIX 15 15 SER A 290 GLY A 302 1 13 HELIX 16 16 THR A 308 ASP A 312 5 5 HELIX 17 17 ASP A 313 ASN A 318 1 6 HELIX 18 18 ASP A 319 HIS A 331 1 13 HELIX 19 19 LYS A 340 GLN A 357 1 18 HELIX 20 20 ASP A 363 MET A 379 1 17 SHEET 1 A 5 ALA A 110 GLU A 116 0 SHEET 2 A 5 TYR A 262 PHE A 270 -1 N GLY A 264 O GLU A 116 SHEET 3 A 5 LEU A 62 ALA A 66 -1 O PHE A 63 N TYR A 269 SHEET 4 A 5 GLY A 6 HIS A 12 1 O VAL A 9 N LEU A 62 SHEET 5 A 5 VAL A 36 GLN A 42 1 N GLU A 37 O GLY A 6 SHEET 1 B 3 ALA A 110 GLU A 116 0 SHEET 2 B 3 TYR A 262 PHE A 270 -1 N GLY A 264 O GLU A 116 SHEET 3 B 3 TYR A 333 LEU A 334 1 O TYR A 333 N GLY A 263 SHEET 1 C 2 GLN A 103 TYR A 104 0 SHEET 2 C 2 HIS A 107 TYR A 108 -1 O HIS A 107 N TYR A 104 SHEET 1 D 3 MET A 224 ASN A 227 0 SHEET 2 D 3 ALA A 119 ASN A 123 -1 N ALA A 119 O ASN A 227 SHEET 3 D 3 PHE A 242 VAL A 245 -1 O GLY A 243 N TYR A 122 SHEET 1 E 2 PHE A 175 ASP A 176 0 SHEET 2 E 2 GLN A 181 PRO A 182 -1 O GLN A 181 N ASP A 176 SHEET 1 F 2 ILE A 250 LYS A 252 0 SHEET 2 F 2 LYS A 255 TYR A 257 -1 N LYS A 255 O LYS A 252 LINK C LEU A 32 N CME A 33 1555 1555 1.33 LINK C CME A 33 N PRO A 34 1555 1555 1.32 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.46 LINK O4 GLC B 2 C1 GLC B 3 1555 1555 1.48 CRYST1 61.118 68.832 127.726 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016362 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014528 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007829 0.00000